交易 Pfizer Inc - PFE CFD
新增到我的最愛- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
| 價差 | 0.06 | ||||||||
|
多頭倉位隔夜費用
Long position overnight fee
前往平台 | -0.024068% | ||||||||
|
空頭倉位隔夜費用
Short position overnight fee
前往平台 | 0.001846% | ||||||||
| 隔夜費時間 | 21:00 (UTC) | ||||||||
| 最小成交量 | 1 | ||||||||
| 貨幣 | USD | ||||||||
| 保證金 | 20% | ||||||||
| 股票交易 | United States of America | ||||||||
| 交易委員會 | 0% |
*Information provided by Capital.com
Pfizer Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
| 日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
|---|---|---|---|---|---|---|
| Mar 28, 2023 | 39.89 | -0.18 | -0.45% | 40.07 | 40.27 | 39.84 |
| Mar 27, 2023 | 40.14 | -0.20 | -0.50% | 40.34 | 40.60 | 39.95 |
| Mar 24, 2023 | 40.30 | 0.26 | 0.65% | 40.04 | 40.43 | 39.85 |
| Mar 23, 2023 | 40.18 | -0.01 | -0.02% | 40.19 | 40.47 | 39.98 |
| Mar 22, 2023 | 40.03 | -0.46 | -1.14% | 40.49 | 40.84 | 39.64 |
| Mar 21, 2023 | 40.60 | -0.04 | -0.10% | 40.64 | 40.95 | 40.29 |
| Mar 20, 2023 | 40.69 | 0.80 | 2.01% | 39.89 | 40.84 | 39.64 |
| Mar 17, 2023 | 40.09 | -0.26 | -0.64% | 40.35 | 40.76 | 39.96 |
| Mar 16, 2023 | 40.36 | 0.32 | 0.80% | 40.04 | 40.47 | 39.70 |
| Mar 15, 2023 | 40.11 | 0.37 | 0.93% | 39.74 | 40.50 | 39.39 |
| Mar 14, 2023 | 39.69 | -0.32 | -0.80% | 40.01 | 40.18 | 39.38 |
| Mar 13, 2023 | 39.94 | 0.38 | 0.96% | 39.56 | 40.48 | 37.95 |
| Mar 10, 2023 | 39.38 | 0.07 | 0.18% | 39.31 | 39.91 | 38.99 |
| Mar 9, 2023 | 39.39 | -0.60 | -1.50% | 39.99 | 40.55 | 39.29 |
| Mar 8, 2023 | 40.09 | -0.25 | -0.62% | 40.34 | 40.54 | 39.88 |
| Mar 7, 2023 | 40.34 | -0.65 | -1.59% | 40.99 | 41.11 | 40.08 |
| Mar 6, 2023 | 40.99 | -0.02 | -0.05% | 41.01 | 41.24 | 40.79 |
| Mar 3, 2023 | 41.06 | 0.48 | 1.18% | 40.58 | 41.15 | 40.19 |
| Mar 2, 2023 | 40.19 | 0.05 | 0.12% | 40.14 | 40.75 | 39.78 |
| Mar 1, 2023 | 40.11 | -0.56 | -1.38% | 40.67 | 40.90 | 40.09 |
Pfizer Inc Events
| 时间（协调世界时） (UTC) | 国家 | 事件 |
|---|---|---|
| Friday, April 28, 2023 | ||
| 时间（协调世界时） (UTC) 13:00 | 国家 US
| 事件 Pfizer Inc Annual Shareholders Meeting Pfizer Inc Annual Shareholders MeetingForecast -Previous - |
| Monday, May 1, 2023 | ||
| 时间（协调世界时） (UTC) 12:30 | 国家 US
| 事件 Q1 2023 Pfizer Inc Earnings Release Q1 2023 Pfizer Inc Earnings ReleaseForecast -Previous - |
| Thursday, May 18, 2023 | ||
| 时间（协调世界时） (UTC) 10:59 | 国家 IN
| 事件 Q4 2023 Pfizer Ltd Earnings Release Q4 2023 Pfizer Ltd Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| 總收入 | 100330 | 81288 | 41651 | 41172 | 40825 |
| 收入 | 100330 | 81288 | 41651 | 41172 | 40825 |
| 收入成本，共計 | 34591 | 30688 | 8405 | 8043 | 8872 |
| 毛利 | 65739 | 50600 | 33246 | 33129 | 31953 |
| 總營業費用 | 63779 | 57636 | 33839 | 28841 | 36763 |
| 銷售/一般/行政費用，總計 | 14305 | 12256 | 11402 | 12485 | 12419 |
| 研究與開發 | 12381 | 11582 | 9340 | 7731 | 7713 |
| Depreciation / Amortization | 3609 | 3700 | 3348 | 4462 | 4736 |
| 異常費用（收入） | 1077 | 3897 | 2619 | -2914 | 4675 |
| Other Operating Expenses, Total | -2184 | -4487 | -1275 | -966 | -1652 |
| 營業收入 | 36551 | 23652 | 7812 | 12331 | 4062 |
| 利息收入（費用），非經營淨值 | -1824 | 560 | -538 | -877 | -538 |
| Gain (Loss) on Sale of Assets | 0 | 99 | -237 | 32 | 71 |
| 稅前淨收入 | 34729 | 24311 | 7036 | 11485 | 3594 |
| 稅後淨收入 | 31401 | 22459 | 6666 | 10545 | 3264 |
| 少數股東權益 | -35 | -45 | -36 | -29 | -36 |
| 未計算非常項目前的淨收益 | 31366 | 22414 | 6630 | 10516 | 3228 |
| 非常規項目總計 | 6 | -434 | 2529 | 5757 | 7924 |
| 淨收入 | 31372 | 21980 | 9159 | 16273 | 11152 |
| Total Adjustments to Net Income | -1 | 0 | -1 | 0 | |
| 普通股股東可獲收益 (不含非經常性項目) | 31366 | 22413 | 6630 | 10515 | 3228 |
| 普通股股東可獲收益 (含非經常性項目) | 31372 | 21979 | 9159 | 16272 | 11152 |
| 攤薄淨收入 | 31372 | 21979 | 9159 | 16272 | 11152 |
| 攤薄後加權平均股 | 5733 | 5708 | 5632 | 5675 | 5977 |
| 扣除特別項目的每股攤薄盈利 | 5.47113 | 3.92659 | 1.1772 | 1.85286 | 0.54007 |
| Dividends per Share - Common Stock Primary Issue | 1.6 | 1.56 | 1.52 | 1.44 | 1.36 |
| 每股正常攤薄盈利 | 5.36543 | 4.09303 | 1.45366 | 1.22837 | 1.04885 |
| 其他，淨值 | 2 | -1 | -1 | -1 |
| Dec 2022 | Oct 2022 | Jul 2022 | Apr 2022 | Dec 2021 | |
|---|---|---|---|---|---|
| 總收入 | 24290 | 22638 | 27742 | 25661 | 23635 |
| 收入 | 24290 | 22638 | 27742 | 25661 | 23635 |
| 收入成本，共計 | 9821 | 6088 | 8671 | 10010 | 9611 |
| 毛利 | 14469 | 16550 | 19071 | 15651 | 14024 |
| 總營業費用 | 19124 | 13226 | 15640 | 15788 | 19059 |
| 銷售/一般/行政費用，總計 | 4877 | 3542 | 3197 | 2691 | 4069 |
| 研究與開發 | 3688 | 3220 | 2816 | 2655 | 4565 |
| Depreciation / Amortization | 1131 | 822 | 822 | 835 | 916 |
| 異常費用（收入） | 643 | 288 | 23 | 122 | 1283 |
| Other Operating Expenses, Total | -1036 | -734 | 111 | -525 | -1385 |
| 營業收入 | 5166 | 9412 | 12102 | 9873 | 4576 |
| 利息收入（費用），非經營淨值 | 57 | -403 | -655 | -823 | -394 |
| Gain (Loss) on Sale of Assets | 6 | -7 | 0 | 1 | 0 |
| 其他，淨值 | 2 | -1 | -1 | 1 | |
| 稅前淨收入 | 5231 | 9001 | 11447 | 9050 | 4183 |
| 稅後淨收入 | 5001 | 8645 | 9877 | 7878 | 3849 |
| 少數股東權益 | -8 | -15 | -6 | -6 | 2 |
| 未計算非常項目前的淨收益 | 4993 | 8630 | 9871 | 7872 | 3851 |
| 非常規項目總計 | 2 | -21 | 34 | -9 | -458 |
| 淨收入 | 4995 | 8609 | 9905 | 7863 | 3393 |
| Total Adjustments to Net Income | -1 | -1 | 1 | 1 | |
| 普通股股東可獲收益 (不含非經常性項目) | 4992 | 8629 | 9872 | 7873 | 3851 |
| 普通股股東可獲收益 (含非經常性項目) | 4994 | 8608 | 9906 | 7864 | 3393 |
| 攤薄淨收入 | 4994 | 8608 | 9906 | 7864 | 3393 |
| 攤薄後加權平均股 | 5745 | 5718 | 5712 | 5758 | 5768 |
| 扣除特別項目的每股攤薄盈利 | 0.86893 | 1.50909 | 1.72829 | 1.36732 | 0.66765 |
| Dividends per Share - Common Stock Primary Issue | 0.4 | 0.4 | 0.4 | 0.4 | 0.39 |
| 每股正常攤薄盈利 | 0.87955 | 1.54162 | 1.63585 | 1.31052 | 0.74896 |
- 年度
- 每季度
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| 流動資産總額 | 59693 | 35067 | 32803 | 49926 | 41141 |
| 現金和短期投資 | 31069 | 12221 | 9646 | 18833 | 19992 |
| 現金等價物 | 1944 | 1784 | 1121 | 1139 | 1342 |
| 短期投資 | 29125 | 10437 | 8525 | 17694 | 18650 |
| 應收賬款總額，淨額 | 11479 | 7930 | 6772 | 8025 | 8221 |
| Accounts Receivable - Trade, Net | 11479 | 7930 | 6772 | 8025 | 8221 |
| Total Inventory | 9059 | 8046 | 7068 | 7508 | 7578 |
| Other Current Assets, Total | 8086 | 6870 | 9317 | 15560 | 5350 |
| Total Assets | 181476 | 154229 | 167594 | 159422 | 171797 |
| Property/Plant/Equipment, Total - Net | 17721 | 15293 | 14258 | 13385 | 13865 |
| Property/Plant/Equipment, Total - Gross | 32794 | 30104 | 29248 | 29977 | 30037 |
| Accumulated Depreciation, Total | -15074 | -14812 | -14990 | -16591 | -16172 |
| Goodwill, Net | 49208 | 49577 | 48202 | 53411 | 55952 |
| Intangibles, Net | 25146 | 28471 | 33936 | 35211 | 48741 |
| Long Term Investments | 21526 | 20262 | 20147 | 2767 | 7015 |
| Other Long Term Assets, Total | 8182 | 5559 | 18248 | 4722 | 5083 |
| Total Current Liabilities | 42671 | 25920 | 37304 | 31858 | 30427 |
| Accounts Payable | 5578 | 4309 | 3887 | 4674 | 4656 |
| Accrued Expenses | 3781 | 3379 | 2659 | 2397 | 2196 |
| Notes Payable/Short Term Debt | 605 | 701 | 14733 | 4055 | 6407 |
| Current Port. of LT Debt/Capital Leases | 1636 | 2002 | 1462 | 4776 | 3546 |
| Other Current Liabilities, Total | 31071 | 15529 | 14563 | 15956 | 13622 |
| Total Liabilities | 104276 | 90991 | 104450 | 96015 | 100489 |
| Total Long Term Debt | 36195 | 37133 | 35955 | 32909 | 33538 |
| Long Term Debt | 36195 | 37133 | 35955 | 32909 | 33538 |
| Deferred Income Tax | 349 | 4063 | 5652 | 3700 | 3900 |
| Minority Interest | 262 | 235 | 303 | 351 | 348 |
| Other Liabilities, Total | 24799 | 23640 | 25236 | 27197 | 32276 |
| Total Equity | 77200 | 63238 | 63144 | 63407 | 71308 |
| Preferred Stock - Non Redeemable, Net | 0 | 17 | 19 | 21 | |
| Common Stock | 473 | 470 | 468 | 467 | 464 |
| Additional Paid-In Capital | 90591 | 88674 | 87428 | 86253 | 84278 |
| Retained Earnings (Accumulated Deficit) | 103394 | 96770 | 97670 | 89554 | 85291 |
| Treasury Stock - Common | -111361 | -110988 | -110801 | -101610 | -89425 |
| Unrealized Gain (Loss) | -220 | 116 | -35 | -68 | 401 |
| Other Equity, Total | -5677 | -11804 | -11603 | -11208 | -9722 |
| Total Liabilities & Shareholders’ Equity | 181476 | 154229 | 167594 | 159422 | 171797 |
| Total Common Shares Outstanding | 5620 | 5567 | 5534 | 5717 | 5979 |
| Total Preferred Shares Outstanding | 0 | 0 | 0.00043 | 0.00048 | 0.00052 |
| Apr 2022 | Dec 2021 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| 流動資産總額 | 54420 | 59693 | 57900 | 48814 | 39533 |
| 現金和短期投資 | 23897 | 31069 | 29696 | 21700 | 13667 |
| 現金等價物 | 2470 | 1944 | 1966 | 2372 | 1768 |
| 短期投資 | 21427 | 29125 | 27730 | 19328 | 11899 |
| 應收賬款總額，淨額 | 13225 | 11479 | 11897 | 10587 | 9864 |
| Accounts Receivable - Trade, Net | 13225 | 11479 | 11897 | 10587 | 9864 |
| Total Inventory | 9979 | 9059 | 8640 | 8948 | 8493 |
| Other Current Assets, Total | 7319 | 8086 | 7667 | 7579 | 7509 |
| Total Assets | 183841 | 181476 | 179188 | 169920 | 158818 |
| Property/Plant/Equipment, Total - Net | 15109 | 14882 | 14436 | 14224 | 14011 |
| Property/Plant/Equipment, Total - Gross | 30467 | 29955 | 29839 | 29552 | 29116 |
| Accumulated Depreciation, Total | -15358 | -15074 | -15403 | -15328 | -15105 |
| Goodwill, Net | 50211 | 49208 | 49489 | 49867 | 49791 |
| Intangibles, Net | 29816 | 25146 | 26306 | 27323 | 27974 |
| Long Term Investments | 20737 | 21526 | 21597 | 20942 | 20228 |
| Other Long Term Assets, Total | 13548 | 11021 | 9460 | 8750 | 7281 |
| Total Current Liabilities | 39268 | 42671 | 41803 | 35664 | 26652 |
| Accounts Payable | 5506 | 5578 | 4698 | 4327 | 4064 |
| Accrued Expenses | 2249 | 3332 | 2571 | 2015 | 1985 |
| Notes Payable/Short Term Debt | 385 | 605 | 966 | 201 | 676 |
| Current Port. of LT Debt/Capital Leases | 260 | 1636 | 2663 | 3687 | 3676 |
| Other Current Liabilities, Total | 30868 | 31520 | 30905 | 25434 | 16251 |
| Total Liabilities | 101417 | 104276 | 103496 | 99878 | 90198 |
| Total Long Term Debt | 35656 | 36195 | 36250 | 35354 | 35347 |
| Long Term Debt | 35656 | 36195 | 36250 | 35354 | 35347 |
| Deferred Income Tax | 655 | 349 | 328 | 4161 | 4355 |
| Minority Interest | 261 | 262 | 275 | 273 | 245 |
| Other Liabilities, Total | 25577 | 24799 | 24840 | 24426 | 23599 |
| Total Equity | 82424 | 77200 | 75692 | 70042 | 68620 |
| Common Stock | 476 | 473 | 473 | 472 | 472 |
| Additional Paid-In Capital | 90844 | 90591 | 89973 | 89336 | 89002 |
| Retained Earnings (Accumulated Deficit) | 111193 | 103394 | 102252 | 96346 | 95158 |
| Treasury Stock - Common | -113931 | -111361 | -111359 | -111356 | -111349 |
| Unrealized Gain (Loss) | -133 | -220 | -146 | 79 | -26 |
| Other Equity, Total | -6025 | -5677 | -5501 | -4835 | -4637 |
| Total Liabilities & Shareholders’ Equity | 183841 | 181476 | 179188 | 169920 | 158818 |
| Total Common Shares Outstanding | 5591 | 5620 | 5611 | 5599 | 5594 |
| Total Preferred Shares Outstanding | 0 |
- 年度
- 每季度
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| 淨收入/起跑線 | 22025 | 9652 | 16302 | 11188 | 21355 |
| 經營活動産生的現金 | 32580 | 14403 | 12587 | 15827 | 16802 |
| 經營活動産生的現金 | 5191 | 4777 | 6010 | 6384 | 6269 |
| Deferred Taxes | -4293 | -1468 | 614 | -2205 | -2410 |
| 非現金物品 | -3147 | 1717 | -6307 | 1387 | -9748 |
| Cash Taxes Paid | 7427 | 3153 | 3664 | 3655 | 2489 |
| 已付現金利息 | 1467 | 1641 | 1587 | 1311 | 1518 |
| 營運資金的變化 | 12804 | -275 | -4032 | -927 | 1336 |
| 投資活動産生的現金 | -22546 | -4271 | -3945 | 4525 | -4740 |
| 資本支出 | -2711 | -2791 | -2594 | -2196 | -2217 |
| 其他投資現金流量項目，總計 | -19835 | -1480 | -1351 | 6721 | -2523 |
| 融資活動産生的現金 | -9816 | -9649 | -8485 | -20441 | -13350 |
| 融資現金流項目 | 16 | 11121 | -735 | -589 | -612 |
| Total Cash Dividends Paid | -8729 | -8440 | -8043 | -7978 | -7659 |
| 股票的發行（報廢），淨額 | 0 | 425 | -8471 | -10939 | -4138 |
| 債務的發行（退還），淨額 | -1103 | -12755 | 8764 | -935 | -941 |
| 外彙效應 | -59 | -8 | -32 | -116 | 53 |
| 現金淨變化 | 159 | 475 | 125 | -205 | -1235 |
| Apr 2022 | Dec 2021 | Oct 2021 | Jul 2021 | Apr 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 7870 | 22025 | 18633 | 10475 | 4886 |
| Cash From Operating Activities | 6541 | 32580 | 26666 | 15836 | 4539 |
| Cash From Operating Activities | 1187 | 5191 | 3914 | 2554 | 1226 |
| Deferred Taxes | -2321 | -4293 | -3702 | 199 | |
| Non-Cash Items | 537 | -3147 | -2997 | -1590 | -446 |
| Cash Taxes Paid | 354 | 7427 | 2943 | 2188 | 394 |
| Cash Interest Paid | 453 | 1467 | 1205 | 798 | 445 |
| Changes in Working Capital | -732 | 12804 | 10818 | 4397 | -1326 |
| Cash From Investing Activities | 567 | -22546 | -19960 | -9884 | -1747 |
| Capital Expenditures | -643 | -2711 | -1718 | -1094 | -554 |
| Other Investing Cash Flow Items, Total | 1210 | -19835 | -18242 | -8790 | -1193 |
| Cash From Financing Activities | -6578 | -9816 | -6465 | -5364 | -2807 |
| Financing Cash Flow Items | -500 | 16 | -185 | -510 | -610 |
| Total Cash Dividends Paid | -2249 | -8729 | -6540 | -4355 | -2172 |
| Issuance (Retirement) of Debt, Net | -1829 | -1103 | 260 | -499 | -25 |
| Foreign Exchange Effects | -1 | -59 | -32 | 5 | 0 |
| Net Change in Cash | 529 | 159 | 209 | 593 | -15 |
| Issuance (Retirement) of Stock, Net | -2000 | 0 |
| 投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.8399 | 498960132 | 7958928 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.2022 | 293632997 | 7445623 | 2022-12-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.0342 | 284152008 | -3460733 | 2022-12-31 | LOW |
| Capital World Investors | Investment Advisor | 4.5372 | 256096804 | 7246275 | 2022-12-31 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 3.5315 | 199329574 | -11544578 | 2022-12-31 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.936 | 109275578 | -1166562 | 2022-12-31 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 1.2993 | 73340479 | 3216573 | 2022-12-31 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.0893 | 61484622 | 4721018 | 2022-12-31 | LOW |
| Capital International Investors | Investment Advisor | 1.033 | 58305623 | 2981745 | 2022-12-31 | LOW |
| State Farm Insurance Companies | Insurance Company | 0.9491 | 53568997 | 0 | 2022-12-31 | LOW |
| MFS Investment Management | Investment Advisor/Hedge Fund | 0.861 | 48600901 | 7694324 | 2022-12-31 | LOW |
| BofA Global Research (US) | Research Firm | 0.8017 | 45253527 | 178774 | 2022-12-31 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.762 | 43007793 | 174840 | 2022-12-31 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.746 | 42104919 | 862505 | 2022-12-31 | LOW |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 0.7418 | 41867862 | 537506 | 2022-12-31 | LOW |
| Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7287 | 41132806 | -681703 | 2022-12-31 | LOW |
| BlackRock Asset Management Ireland Limited | Investment Advisor | 0.6777 | 38249940 | 1808532 | 2022-12-31 | LOW |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.6115 | 34512955 | -965973 | 2022-12-31 | LOW |
| T. Rowe Price Associates, Inc. | Investment Advisor | 0.5051 | 28510788 | -651982 | 2022-12-31 | LOW |
| Mellon Investments Corporation | Investment Advisor/Hedge Fund | 0.4907 | 27694689 | -1220724 | 2022-12-31 | LOW |
差價合約交易計算器
如果您在特定日期（選取一個日期）開立差價合約交易並在不同日期（選取一個日期）關閉交易，計算您的假設盈虧。
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模（槓桿 x 投資）：
打開
關閉
做空 做多
| Industry: | Pharmaceuticals (NEC) |
66 Hudson Boulevard East
NEW YORK
NEW YORK 10001-2192
US
收入報表
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商？
加入全球 500.000 多名交易者，選擇與 Capital.com 交易